Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 10, 2016, Pages

  Carson, Jeffrey L ^a   Stanworth, Simon J ^b   Roubinian, Nareg ^c   Fergusson, Dean A ^c   Triulzi, Darrell ^d   Doree, Carolyn ^b   Hebert, Paul C ^e  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A;

ANEMIA; BACTEREMIA; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONGESTIVE HEART FAILURE; ERYTHROCYTE TRANSFUSION; FATIGUE; HEART INFARCTION; HEART SURGERY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL MORTALITY; HUMAN; KIDNEY FAILURE; MENTAL DISEASE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SEPSIS; SYSTEMATIC REVIEW; THROMBOEMBOLISM; WOUND INFECTION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD; META ANALYSIS; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; STANDARDS; UTILIZATION;

ANEMIA; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMOGLOBIN A; HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84991213310     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002042.pub4     Document Type: Review

References (109)

1. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. British Journal of Surgery 1986;73(10):783-5.
2. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999;39(10):1070-7.
3. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. American Journal of Surgery 1997;174(2):143-8.
4. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998;38(6):522-9.
5. Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015;385(9974):1183-9.
6. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine 2011;365(26):2453-62.
7. Gruber-Baldini AL, Marcantonio E, Orwig D, Magaziner J, Terrin M, Barr E, et al. Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture. Journal of the American Geriatrics Society 2013;61(8):1286-95.
8. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. American Heart Journal 2013;165(6):964-71.
9. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, Mckenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study). American Journal of Cardiology 2011;108(8):1108-11.
10. de Almeida JP, Vincent JL, Galas FR, de Almeida EP, Fukushima JT, Osawa EA, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 2015;122(1):29-38.
11. DeZern AE, Williams K, Zahurak M, Hand W, Stephens RS, King KE, et al. Red blood cell transfusion triggers in acute leukemia: a randomized pilot study. Transfusion 2016;56(7):1750-7.
12. Fan YX, Liu FF, Jia M, Yang JJ, Shen JC, Zhu GM, et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Archives of Gerontology and Geriatrics 2014;59(1):181-5.
13. Fisher MR, Topley ET. The illness of trauma. British Journal of Clinical Practice 1956;10(11):770-6.
14. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009;49(2):227-34.
15. Gregersen M, Borris LC, Damsgaard EM. Blood transfusion and overall quality of life after hip fracture in frail elderly patients--the transfusion requirements in frail elderly randomized controlled trial. Journal of the Americal Medical Directors Association 2015;16(9):762-6.
16. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthopaedica 2015;86(3):1-10.
17. Gregersen M, Damsgaard EM, Borris LC. Blood transfusion and risk of infection in frail elderly after hip fracture surgery: the TRIFE randomized controlled trial. European Journal of Orthopaedic Surgery & Traumatology 2015;25(6):1031-8.
18. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sanguinis 2006;90(2):105-12.
19. Grover M, Talwalker SA, Contreras, Soni N. Blood transfusion threshold and silent myocardial ischemia after lower limb arthroplasty: a randomized controlled trial of transfusion strategy. Transfusion Alternatives in Transfusion Medicine 2005;7(1 (Suppl)):62-3.
20. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010;304(14):1559-67.
21. Hébert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, et al. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group [published erratum appears in JAMA 1995 Sep 27;274(12):944]. JAMA 1995;273(18):1439-44.
22. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998;38(6):522-9.
23. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New England Journal of Medicine 1999;340(6):409-17.
24. McIntyre L, Hebert PC, Wells G, Fergusson D, Marshall J, Yetisir E, et al. Canadian Critical Care Trials Group. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?. The Journal of Trauma 2004;57(3):563-8.
25. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. New England Journal of Medicine 2014;371(15):1381-91.
26. Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015;386(9989):137-44.
27. Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. Journal of Thoracic and Cardiovascular Surgery 1992;104(2):307-14.
28. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. New England Journal of Medicine 2007;356(16):1609-19.
29. Lotke PA, Barth P, Garino JP, Cook EF. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. Journal of Arthroplasty 1999;14(6):647-50.
30. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. New England Journal of Medicine 2015;372:997-1008.
31. Nielsen K, Johansson PI, Dahl B, Wagner M, Frausing B, Børglum J, et al. Perioperative transfusion threshold and ambulation after hip revision surgery--a randomized trial. BMC Anesthesiology 2014;14:89.
32. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury 2013;44(12):1916-8.
33. Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG 2014;121(8):1005-14.
34. Shehata N, Burns LA, Nathan H, Hebert P, Hare GM, Fergusson D, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012;52(1):91-9.
35. So-Osman C. A restrictive transfusion trigger is a method for blood saving in elective orthopaedic surgery. Vox Sanguinis 2004;87(Suppl 3):52.
36. So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfusion (Trasfusione del sangue) 2013;11(2):289-95.
37. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sanguinis 2010;98(1):56-64.
38. Colomo A, Hernandez-Gea V, Muniz-Diaz E, Madoz P, Aracil C, Alvarez-Urturi C. Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding. Hepatology 2008;48(4 (Suppl)):413A.
39. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine 2013;368(1):11-21.
40. Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Critical Care Medicine 2013;41(10):2354-63.
41. Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008;48(1):81-91.
42. Fortune JB, Feustel PJ, Saifi J, Stratton HH, Newell JC, Shah DM. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. The Journal of Trauma 1987;27(3):243-9.
43. Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 2014;312(1):36-47.
44. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. New England Journal of Medicine 1995;333(4):206-13.
45. Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury. Critical Care Medicine 2009;37(3):1074-8.
46. ISRCTN26088319 Red cell transfusion and QoL in myelodysplastic syndromes [Red blood cell transfusion thresholds and quality of life in myelodysplastic syndromes: a pilot, feasibility study]. www.isrctn.com/ISRCTN26088319 (first received 13 November 2014).
47. NCT02203292 Transfusion requirements after head trauma (TRAHT). www.clinicaltrials.gov/ct2/show/NCT02203292 (first received 26 July 2014).
48. NCT01079247 A trial of restrictive versus traditional blood transfusion practices in burn patients [A randomized clinical trial of restrictive vs. traditional blood transfusion practices in burn patients]. www.clinicaltrials.gov/ct2/show/NCT01079247 2010 (accessed 9/9/16).
49. NCT02042898 Transfusion requirements in cardiac surgery III (TRICS-III) [An international, multi-centre, randomized controlled trial to assess transfusion thresholds in patients undergoing cardiac surgery]. www.clinicaltrials.gov/ct2/show/NCT02042898 2014 (accessed 9/9/16).
50. NCT02099669 Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC) [Red blood cell transfusion thresholds and QOL in MDS (EnhanceRBC): a pilot, feasibility study]. www.clinicaltrials.gov/ct2/show/NCT02099669 2014 (accessed 9/9/16).
51. NCT02465125 The transfusion triggers in vascular surgery trial (TV) [The transfusion triggers in vascular surgery trial: two different transfusion triggers for postoperative haemoglobin separation and adherence to transfusion strategies in vascular surgery: a randomised clinical feasibility trial]. www.clinicaltrials.gov/ct2/show/NCT02465125 2015 (accessed 9/9/16).
52. NCT02483351 Aneurysmal subarachnoid hemorrhage: red blood cell transfusion and outcome (SAHaRA Pilot) [Aneurysmal subarachnoid hemorrhage: red blood cell transfusion and outcome - a pilot randomized controlled trial]. www.clinicaltrials.gov/ct2/show/NCT02483351 2015 (accessed 9/9/16).
53. NCT02619136 Myocardial ischemia and transfusion (MINT) [Myocardial ischemia and transfusion: a pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction]. www.clinicaltrials.gov/ct2/show/NCT02619136 2015 (accessed 9/9/16).
54. NCT02648113 Cost-effectiveness and cost-utility of liberal vs restrictive red blood cell transfusion strategies in patients with acute myocardial infarction and anaemia (REALITY). www.clinicaltrials.gov/ct2/show/NCT02648113 2016 (accessed 9/9/16).
55. NTR3244 Blood transfusion study in patients at risk for cardiac complications after non-cardiac surgery [Perioperative Transfusion Study (PETS): does a liberal transfusion protocol improve outcome in high-risk cardiovascular patients undergoing non-cardiac surgery?]. www.trialregister.nl/trialreg/admin/rctview.asp?TC=3244 2012 (accessed 9/9/16).
56. NCT01237639 Study of red blood cell transfusion triggers in patients undergoing hematopoietic stem cell transplantation (TRIST) [Transfusion of red cells in hematopoietic stem cell transplantation: the TRIST Study]. www.clinicaltrials.gov/ct2/show/NCT01237639 2010 (accessed 9/9/16).
57. Tay J, Tinmouth A, Fergusson D, Allan D. Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial. Trials 2011;12:207.
58. Association of Anaesthetists of Great Britain and Ireland. Blood transfusion and the anaesthetist - red cell transfusion. www.aagbi.org/publications/guidelines/docs/red_cell_08.pdf 2008 (accessed 11 October 2016).
59. American Society of Anesthesiologists (ASA) Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105(1):198-208.
60. British Columbia Transfusion Medicine Advisory Group (BCTMAG). Guidelines for red blood cell transfusion. British Columbia Transfusion Medicine Advisory Group 2003; Vol. November:1-3.
61. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. New England Journal of Medicine 2000;342(25):1878-86.
62. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD001888.pub4]
63. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348(9034):1055-60.
64. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2012;157(1):49-58.
65. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Internal Medicine 2013;173(2):132-9.
66. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine 2000;342(25):1887-92.
67. Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, et al. Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016 Apr 12 [Epub ahead of print]. [DOI: 10.1016/S0140-6736(15)01313-6]
68. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
69. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Ddungu H, Kyeyune D, Musisi E, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 2015;314(23):2514-23.
70. Fergusson D, Tinmouth A. Storage age of red blood cells for transfusion of premature infants--reply. JAMA 2013;309(6):545.
71. Fominskiy E, Putzu A, Monaco F, Scandroglio AM, Karaskov A, Galas FR, et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. British Journal of Anaesthesia 2015;115(4):511-9.
72. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD001886.pub4]
73. Higgins JP, Green S, editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
74. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 2015;350:h1354.
75. Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. American Journal of Respiratory and Critical Care Medicine 1997;155(5):1618-23.
76. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007;370(9585):415-26.
77. Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, et al. Age of transfused blood in critically ill adults. New England Journal of Medicine 2015;372(15):1410-8.
78. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
79. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. British Journal of Anaesthesia 2005;95(1):33-42.
80. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Critical Care Medicine 2008;36(9):2667-74.
81. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Critical Care Medicine 2009;37(12):3124-57.
82. National Blood Users Group Ireland (NBUGI). A guideline for transfusion of red blood cells in surgical patients. www.dohc.ie/publications/transfusion_of_red_blood_cells.html (accessed 11 October 2016).
83. National Institutes of Health (NIH). Perioperative red blood cell transfusion. JAMA 1988;260(18):2700-3.
84. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. British Journal of Haematology 2013;160(4):445-64.
85. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
86. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.1. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
87. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014;311(13):1317-26.
88. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111(16):2042-9.
89. Schulz KF, Chalmers I, Hayes RJ, Altman DJ. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled clinical trials. JAMA 1995;273(5):408-12.
90. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Flasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Review of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
91. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50(4):753-65.
92. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 2014;54(10 Pt 2):2688-95.
93. Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Journal of Thoracic & Cardiovascular Surgery 1998;116(3):460-7.
94. Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. New England Journal of Medicine 2015;372(15):1419-29.
95. Society of Thoracic Surgeons Blood Conservation Guideline Task Force (STSBCGTF), Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. The Annals of Thoracic Surgery 2011;91(3):944-82.
96. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119(7):1757-67.
97. Wang JK, Klein HG. Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger. Vox Sanguinis 2010;98(1):2-11.
98. U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health. Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. www.hhs.gov/ophs/bloodsafety/2007nbcus_survey.pdf (accessed 11 October 2016).
99. WHO Blood safety: key global facts and figures in 2011. www.who.int/worldblooddonorday/media/who_blood_safety_factsheet_2011.pdf (accessed 11 October 2016); Vol. Fact Sheet 279:1-9.
100. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. New England Journal of Medicine 2001;345(17):1230-6.
101. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007;297(22):2481-8.
102. Wu WC, Smith TS, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Annals of Surgery 2010;252(1):11-7.
103. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009;49(8):1609-20.
104. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50(7):1495-504.
105. Carless PA, Henry DA, Carson JL, Hebert PPC, McClelland B, Ker K. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD002042.pub2]
106. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3]
107. Hill S, Carless PA, Henry DA, Carson JL, Hebert PPC, Henderson KM, et al. Transfusion thresholds and otherstrategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD002042]
108. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD002042]
109. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DBL, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002042]